Pulmonary Function using Impulse Oscillometry System and Clinical Outcomes at Age 4 Years in Children Born Extremely Preterm with or without Bronchopulmonary Dysplasia

RECOMMENDED

Further Publications

Combining artificial intelligence and conventional statistics to predict bronchopulmonary dysplasia in very preterm infants using routinely collected clinical variables

★ 1 Recommended by Dr Martin Frey, Faculty Member

Pediatr Pulmonol

Montagna S, Magno D, Ferretti S, Stelluti M, Gona A, Dionisi C, Simonazzi G, Martini S, Corvaglia L, Aceti A

doi: 10.1002/ppul.27216

Pulmonary Fibrosis

LONGITUDE: An observational study of the long-term effectiveness of elexacaftor/tezacaftor/ivacaftor in people aged ≥12 years with cystic fibrosis using data from the United Kingdom Cystic Fibrosis Registry - 2-year analysis

J Cyst Fibros

Vega-Hernandez G, MacGregor G, Wilfin A, Adams F, Haugh C, Baxter CA, Wöhling H, Clarke SL, Charman SC, Carr SB

doi: 10.1016/j.jcf.2025.04.012

RECOMMENDED

Pulmonary HypertensionBronchi

Bronchopulmonary dysplasia and ventilation-associated outcomes after pediatric tracheostomy

★ 1 Recommended by Dr Martin Frey, Faculty Member

Pediatr Pulmonol

Chorney SR, Beams DR, Nadar A, Afolabi F, Gelfand A, Brooks R, Kou YF, Johnson RF

doi: 10.1002/ppul.27247

RECOMMENDED

Further Publications

Long-term lung function follow-up of preterm infants less than 32 weeks of gestational age

★ 2 Recommended by Dr Martin Frey, Faculty Member

Pediatr Pulmonol

Merino-Hernández A, Muñoz-Cutillas A, Ramos-Navarro C, Bellón-Alonso S, Rodríguez-Cimadevilla JL, González-Pacheco N, Rodríguez-Fernández R, Sánchez-Luna M

doi: 10.1002/ppul.27158

RECOMMENDED

Pulmonary Hypertension

Impact of Preoperative Body Mass Index on Long-term Survival, Quality of Life, and Functional Outcomes after Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension: Results from the UK National Cohort

★ 2 Recommended by Dr Martin Frey, Faculty Member

★ 1 Recommended by Dr Marcus Hesse, Faculty Member

J Heart Lung Transplant

Chiu S, Bunclark K, Appenzeller P, Ghani H, Taboada D, Sheares K, Toshner M, Pepke-Zaba J, Cannon J, Taghavi F, Tsui S, Ng C, Jenkins DP

doi: 10.1016/j.healun.2024.09.005

RECOMMENDED

Pulmonary Hypertension

Low nailfold capillary density in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: biomarker of clinical outcome?

★ 1 Recommended by Dr Martin Frey, Faculty Member

★ 1 Recommended by Dr Marcus Hesse, Faculty Member

Sci Rep

Smits AJ, Isebia K, Combee-Duffy C, van der Wal S, Nossent EJ, Boonstra A, Vonk-Noordegraaf A, Bogaard HJ, Serné EH

doi: 10.1038/s41598-024-69017-y

RECOMMENDED

Pulmonary Fibrosis

Vanzacaftor-tezacaftor-deutivacaftor for children aged 6-11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trial

★ 2 Recommended by Dr Martin Frey, Faculty Member

★ 2 Recommended by Dr Marcus Hesse, Faculty Member

Lancet Respir Med

Hoppe JE, Kasi AS, Pittman JE, Jensen R, Thia LP, Robinson P, Tirakitsoontorn P, Ramsey B, Mall MA, Taylor-Cousar JL, McKone EF, Tullis E, Salinas DB, Zhu J, Chen YC, Rodriguez-Romero V, Sosnay PR, Davies G

doi: 10.1016/S2213-2600(24)00407-7

Pulmonary Fibrosis

Donor age over 55 is associated with worse outcome in lung transplant recipients with idiopathic pulmonary fibrosis

BMC Pulm Med

Moneke I, Ogutur ED, Kornyeva A, Fähndrich S, Schibilsky D, Bierbaum S, Czerny M, Stolz D, Passlick B, Jungraithmayr W, Frye BC

doi: 10.1186/s12890-024-03317-x

RECOMMENDED

Asthma

Immediate and One-Year Outcomes of an Asthma-Tailored Pulmonary Rehabilitation Programme in Overweight and Obese People with Difficult-to-Treat Asthma

★ 2 Recommended by Dr Martin Frey, Faculty Member

★ 1 Recommended by Dr Marcus Hesse, Faculty Member

J Asthma Allergy

Ricketts HC, Sharma V, Steffensen F, Mackay E, MacDonald GW, Buchan DS, Lean M, Chaudhuri R, Cowan DC

doi: 10.2147/JAA.S466894

Related content

Combining artificial intelligence and conventional statistics to predict bronchopulmonary dysplasia in very preterm infants using routinely collected clinical variables

LONGITUDE: An observational study of the long-term effectiveness of elexacaftor/tezacaftor/ivacaftor in people aged ≥12 years with cystic fibrosis using data from the United Kingdom Cystic Fibrosis Registry - 2-year analysis

Bronchopulmonary dysplasia and ventilation-associated outcomes after pediatric tracheostomy

Long-term lung function follow-up of preterm infants less than 32 weeks of gestational age

Impact of Preoperative Body Mass Index on Long-term Survival, Quality of Life, and Functional Outcomes after Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension: Results from the UK National Cohort

Low nailfold capillary density in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: biomarker of clinical outcome?

Vanzacaftor-tezacaftor-deutivacaftor for children aged 6-11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trial

Donor age over 55 is associated with worse outcome in lung transplant recipients with idiopathic pulmonary fibrosis

Immediate and One-Year Outcomes of an Asthma-Tailored Pulmonary Rehabilitation Programme in Overweight and Obese People with Difficult-to-Treat Asthma